HKEX Filings
-
Mar 24, 2025
Voluntary Announcement Clover Announces US IND Clearance and Initiation of Revaccination Clinical Study for RSV Vaccine Candidate SCB-1019
-
Mar 24, 2025Inside Information
-
Mar 24, 2025Postpone of Board Meeting Date
-
Mar 12, 2025Date of Board Meeting
-
Mar 5, 2025Monthly Return of Equity Issuer on Movements in Securities for the Month ended February 28, 2025
-
Feb 6, 2025Monthly Return of Equity Issuer on Movements in Securities for the Month ended January 31, 2025
-
Jan 20, 2025Grant of RSUS Pursuant to the RSU Scheme
-
Jan 6, 2025Monthly Return of Equity Issuer on Movements in Securities for the Month ended December 31, 2024
-
Dec 5, 2024Monthly Return of Equity Issuer on Movements in Securities for the Month ended November 30, 2024
-
Nov 6, 2024Monthly Return of Equity Issuer on Movements in Securities for the Month ended October 31, 2024
-
Nov 6, 2024(Revised) Monthly Return of Equity Issuer on Movements in Securities for the Month ended September 30, 2024
-
Oct 29, 2024Voluntary Announcement Clover Announces Positive Clinical Data for RSV Vaccine Candidate SCB-1019 Compared Head-to-Head Versus GSK'S AREXVY
-
Oct 7, 2024Monthly Return of Equity Issuer on Movements in Securities for the Month ended September 30, 2024
-
Sep 19, 20242024 Interim Report
-
Sep 19, 2024Letter to Registered Shareholders - New Arrangement of Electronic Dissemination of Corporate Communications and Reply Form
-
Sep 3, 2024Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August, 2024
-
Aug 28, 2024Interim Results Announcement for the Six Months Ended Jun 30, 2024
-
Aug 15, 2024Date of Board Meeting
-
Aug 5, 2024Monthly Return of Equity Issuer on Movements in Securities for the Month ended July 31, 2024
-
Jul 17, 2024(Revised) Monthly Return of Equity Issuer on Movements in Securities for the Month ended June 30, 2024
